Healthcare | April 05, 2024
Aster DM Healthcare concludes separation of India and GCC businesses
The company plans to add 1700 beds by FY27 through the organic route
The company plans to add 1700 beds by FY27 through the organic route
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Both the India and GCC entities will be operated by separate dedicated management teams
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)